Author:
Klein Nicola P.,Abu-Elyazeed Remon,Cornish Matthew,Leonardi Michael L.,Weiner Leonard B.,Silas Peter E.,Grogg Stanley E.,Varman Meera,Frenck Robert W.,Cheuvart Brigitte,Baine Yaela,Miller Jacqueline M.,Leyssen Maarten,Mesaros Narcisa,Roy-Ghanta Sumita
Funder
GlaxoSmithKline Biologicals SA
GSK
Merck
Novartis
Sanofi
Regeneron
Pfizer
MedImmune
Sanofi Pasteur
Protein Science
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference28 articles.
1. WHO position paper on Haemophilus influenzae type b (Hib) vaccination. Wkly Epidemiol Rec. 2013;88:413–26.
2. WHO. Data and surveillance on Haemophilus influenzae type b (Hib). Available at: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/sentinel/Hib/en/ [last accessed: 11 July 2016].
3. Prevention and control of Haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices (ACIP);Briere;MMWR Recomm Rep,2014
4. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax);Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2007
5. Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998–2009;Briere;Pediatrics,2012
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献